Tags

Type your tag names separated by a space and hit enter

Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia.
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan 25 [Online ahead of print]EI

Abstract

INTRODUCTION

Biofilm formation causes virulence and resistance in Candida albicans. However, little is known about breakthrough candidemia isolates. We evaluated the antifungal activity of fluconazole, anidulafungin, deoxycholate amphotericin B (dAMB), and amphotericin B lipid complex (ABLC) against biofilms of C. albicans isolated from patients with breakthrough candidemia.

METHODS

The present study used strains of C. albicans isolated from breakthrough and non-breakthrough candidemia patients (control group). The susceptibility of planktonic cells to amphotericin B, anidulafungin, and fluconazole was determined by broth microdilution. Antifungal activity in sessile cells was evaluated using the minimum biofilm eradication concentration (MBEC), metabolic activity was estimated by reducing MTT, and biomass was estimated using crystal violet retention.

RESULTS

The planktonic strains were susceptible to amphotericin B, anidulafungin, and fluconazole, with minimum inhibitory concentrations of 1, ≤0.03, and 2mg/L, respectively. However, fluconazole and anidulafungin did not exert an antifungal effect on biofilms. Additionally, dAMB and ABCL reduced the metabolic activity and biomass. However, eradication was only achieved using 16mg/L dAMB. C. albicans isolates of breakthrough candidemia exhibited strong biofilm production, and the in vitro activity of available therapeutic options was poor.

CONCLUSION

In the present study, only dAMB and ABCL exhibited antibiofilm effects against sessile breakthrough candidemia isolates.

Authors+Show Affiliations

Laboratory of Emerging Infectious Diseases, School of Medicine, Department of Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.Laboratory of Emerging Infectious Diseases, School of Medicine, Department of Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.Laboratory of Emerging Infectious Diseases, School of Medicine, Department of Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.Laboratory of Emerging Infectious Diseases, School of Medicine, Department of Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.Laboratory of Emerging Infectious Diseases, School of Medicine, Department of Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil. Electronic address: felipe.tuon@pucpr.br.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

36707288

Citation

Kraft, Letícia, et al. "Comparison of Amphotericin B Lipid Complex, Deoxycholate Amphotericin B, Fluconazole, and Anidulafungin Activity Against Candida Albicans Biofilm Isolated From Breakthrough Candidemia." Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.), 2023.
Kraft L, Ribeiro VST, Gonçalves GA, et al. Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia. Enferm Infecc Microbiol Clin (Engl Ed). 2023.
Kraft, L., Ribeiro, V. S. T., Gonçalves, G. A., Suss, P. H., & Tuon, F. F. (2023). Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia. Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.). https://doi.org/10.1016/j.eimce.2022.07.009
Kraft L, et al. Comparison of Amphotericin B Lipid Complex, Deoxycholate Amphotericin B, Fluconazole, and Anidulafungin Activity Against Candida Albicans Biofilm Isolated From Breakthrough Candidemia. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan 25; PubMed PMID: 36707288.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia. AU - Kraft,Letícia, AU - Ribeiro,Victoria Stadler Tasca, AU - Gonçalves,Geiziane Aparecida, AU - Suss,Paula Hansen, AU - Tuon,Felipe Francisco, Y1 - 2023/01/25/ PY - 2022/04/20/received PY - 2022/07/19/accepted PY - 2023/1/27/entrez PY - 2023/1/28/pubmed PY - 2023/1/28/medline KW - Antifungals KW - Antifúngico KW - Biofilms KW - Breakthrough candidemia KW - Candida KW - Candidemia KW - Candidemia de brecha JF - Enfermedades infecciosas y microbiologia clinica (English ed.) JO - Enferm Infecc Microbiol Clin (Engl Ed) N2 - INTRODUCTION: Biofilm formation causes virulence and resistance in Candida albicans. However, little is known about breakthrough candidemia isolates. We evaluated the antifungal activity of fluconazole, anidulafungin, deoxycholate amphotericin B (dAMB), and amphotericin B lipid complex (ABLC) against biofilms of C. albicans isolated from patients with breakthrough candidemia. METHODS: The present study used strains of C. albicans isolated from breakthrough and non-breakthrough candidemia patients (control group). The susceptibility of planktonic cells to amphotericin B, anidulafungin, and fluconazole was determined by broth microdilution. Antifungal activity in sessile cells was evaluated using the minimum biofilm eradication concentration (MBEC), metabolic activity was estimated by reducing MTT, and biomass was estimated using crystal violet retention. RESULTS: The planktonic strains were susceptible to amphotericin B, anidulafungin, and fluconazole, with minimum inhibitory concentrations of 1, ≤0.03, and 2mg/L, respectively. However, fluconazole and anidulafungin did not exert an antifungal effect on biofilms. Additionally, dAMB and ABCL reduced the metabolic activity and biomass. However, eradication was only achieved using 16mg/L dAMB. C. albicans isolates of breakthrough candidemia exhibited strong biofilm production, and the in vitro activity of available therapeutic options was poor. CONCLUSION: In the present study, only dAMB and ABCL exhibited antibiofilm effects against sessile breakthrough candidemia isolates. SN - 2529-993X UR - https://www.unboundmedicine.com/medline/citation/36707288/Comparison_of_amphotericin_B_lipid_complex,_deoxycholate_amphotericin_B,_fluconazole,_and_anidulafungin_activity_against_Candida_albicans_biofilm_isolated_from_breakthrough_candidemia. DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.